Ledger.Open graph →
SEC Form D · filed January 11, 2016

Sapience Therapeutics, Inc

Offering
$1.0M
Sold
$300K
Exemption
Rule 506(b)
Industry
Biotechnology
Location
Scarsdale, NY
Type
—

Rule 506(b): private placement to accredited investors, no public advertising.

People & firms on this filing (12)

Robert Ruffolo, Ph.D · Scarsdale, NYDirectorIsaac Blech · Scarsdale, NYDirectorBarry Kappel, Ph.D · Scarsdale, NYExec · DirectorDavid Scheinberg, Ph.D · Scarsdale, NYDirectorIain Ball · VANCOUVER, British Columbia, CanadaDirectorShaun Greffard · VANCOUVER, British Columbia, CanadaExec · DirectorEd Theobald · VANCOUVER, British Columbia, CanadaDirectorSid Paquette · Toronto, Ontario, CanadaDirectorWg Depositor 5, LLC · NASHUA, NHDirectorAlbert F. Fleury · Chevy Chase, MDDirectorPatrick G. Daignault · Montreal, Quebec, CanadaDirectorMary K. Simonson · Phoenix, AZExec · Director

Public SEC Form D (Reg D) filing. · View issuer on SEC EDGAR ↗